New GST rates 2025 full list effective today: The Modi government's next-generation GST reforms take effect on September 22, ...
A list of lifesaving drugs and medicines will get cheaper from Monday, 22 September 2025, after the rate cuts under the new ...
As per the new GST structure, the earlier structure of four tax slabs (5%, 12%, 18%, 28%) has been simplified into two tax slabs (5% and 18%). Additionally, a new 40% slab was introduced for ‘luxury’ ...
The new system, announced earlier this month by Finance Minister Nirmala Sitharaman, has simplified GST into just two main ...
Prices of kitchen staples to electronics, from medicines and equipment to automobiles, will get cheaper from today as reduced ...
GSK to showcase new research from its broad respiratory portfolio at the European Respiratory Society Congress 2025: London, UK Wednesday, September 17, 2025, 11:00 Hrs [IST] GSK ...
Extended treatment with benralizumab led to durable remission, reduced OGC burden, sustained eosinophil depletion, and low relapse rates in patients with EGPA.
GST Rate Cut on Cancer Drugs: Medical expenses especially for cancer patients and those struggling with chronic illnesses are set to go down as GST 2.0 is rolled out with effect from 22 September 2025 ...
Newspoint on MSN
From the first day of Navratri, GST will no longer be levied on these 33 essential medicines, here is the complete list..
The government has made a big decision in the field of health. In the GST Council meeting held on 3 September 2025, GST on 33 such medicines has been abolished, which are especially used in the ...
The evaluation committee considered evidence submitted by AstraZeneca, a review of this submission by the external assessment group (EAG), and responses from stakeholders. See the committee papers for ...
The "Outnumbered" family just got a little larger. Fox News host Kayleigh McEnany has welcomed her third child, a daughter named Avery Grace. The news was shared Monday by McEnany’s co-hosts, who ...
PHILADELPHIA--(BUSINESS WIRE)--GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved Nucala (mepolizumab) as an add-on maintenance treatment for adult ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback